IUL vs Whole Life Insurance: What the $25,000 IUL Challenge Actually Proves

A financial product that has to be defended by its projections rather than its history is telling you where the risk sits. Indexed universal life has been sold for more than two decades on a promise that reads well on paper: upside participation in an index, a floor that protects against loss, flexible premiums, and tax-advantaged income later. The projections are compelling. The record of those projections holding up is the part almost nobody publishes.

That gap is what a standing $25,000 challenge from LIFE180 has been probing for four years. Produce an indexed universal life policy at least ten years old, past its surrender period, sold on current assumptions, that has performed at or better than its original illustration. Hundreds of submissions have come in. None has been paid.

The debate is not whether indexed universal life can work. It is whether the thing you were sold and the thing the contract obligates the carrier to deliver are the same thing. One submission finally cleared the year-ten cash value bar, and it was disallowed on the published terms because it was a survivorship policy funded by a lump sum exchange. The agent who built it argues the terms make the challenge unwinnable. The people running it argue the terms exist because a decade of submissions taught them what gets manipulated.

At BetterWealth we have structured more than 2,000 policies across all 50 states, and we do not use indexed universal life as a capital base. This article covers what the challenge actually tests, why the one qualifying policy still carried a $600,000 per year cost of insurance risk in its late years, where indexed universal life genuinely fits, what The And Asset framework requires from a contract, and the honest cost of the certainty whole life provides.

The illustrations are on screen in the full conversation, including the Monte Carlo run at age 90 and 95 and the whole life comparison built at the same premium. If you want to see the actual columns rather than read about them, start there.

01 / The problemThe gap between what was sold and what is contractually owed

Every permanent life insurance contract splits into two columns, and almost every dispute in this industry lives in the space between them. One column is guaranteed: the carrier is contractually obligated to deliver it. The other column is a current assumption, a projection built on today's crediting rates, today's charges, and today's expectations, and the carrier can adjust most of those inputs within contract limits.

On a whole life contract, the guaranteed column carries the premium, the death benefit, and a cash value floor. The non-guaranteed piece is the dividend, which is declared annually by the board and is not promised. On an indexed universal life contract, the guaranteed column is narrower. Caps, participation rates, spreads, policy charges, and cost of insurance rates all sit on the assumption side, bounded by contract maximums that are typically far worse than what the illustration shows.

The buyer, in most cases, is shown one number: the current assumption projection. That is the number that gets circled on the page.

02 / The challengeWhat is the IUL challenge, and why has nobody won it?

The IUL challenge asks for one specific artifact: an indexed universal life policy, at least ten years old and past its surrender period, whose actual in-force performance matches or beats the original current-assumption illustration it was sold on. The ten-year requirement exists because early-year numbers hide the problem. A policy at year three or year four often looks fine. The strain shows up later, when cost of insurance charges scale against the net amount at risk.

The published terms exclude a handful of categories: policies illustrated below the maximum assumed rate at the time, index swaps after issue, altered premium patterns, survivorship contracts, and lump sum 1035 exchanges. Each exclusion traces back to a real submission pattern. The exclusions are also the heart of the criticism, and it is a fair one to state plainly.

The case against the challenge

The agent who submitted the closest policy argues the terms give the sponsor discretion broad enough to invalidate almost anything: language disallowing overfunded designs "at sole and absolute discretion," a clause allowing terms to change without notice, and an exclusion for guaranteed or principal-protected products that, read literally, could sweep in any policy carrying a no-lapse guarantee. His conclusion is that a four-year record of zero payouts under discretionary terms is not proof about the product.

That argument deserves a real answer rather than a dismissal. Here is ours: the terms are worth tightening, and the underlying observation still stands on its own without the challenge. We just lived through one of the strongest equity runs in market history. A product sold on upside participation should have had its best possible decade. The submissions that did arrive were not close.

The prize is a device. The decade is the evidence.

03 / The frameworkWhat does The And Asset require from a policy?

The And Asset requires a capital base you can price before you deploy it, which is a stricter requirement than most people apply to permanent insurance. Our framework says a properly structured whole life policy functions as a capital base you borrow against while the policy keeps compounding on its full value, net of mortality and expense charges. The discipline attached to it is the whole strategy.

Nelson Nash pioneered the idea of using whole life insurance as a personal banking system, and his insight about lost opportunity cost is foundational. We credit that. The And Asset builds on his foundation and operates on different principles.

Where IBC ends and The And Asset begins

IBC says you can use a whole life policy as a personal banking system for any purchase. The And Asset says you only deploy capital when the borrowed dollars will produce a return greater than the carrier's loan cost, because anything less is an expensive way to spend money. Many IBC marketers say you are paying yourself interest. You are not. The interest goes to the carrier. Your return is what the deployed capital earns elsewhere while the policy compounds uninterrupted.

That rule has a hard technical consequence for product selection. To run the test, you have to know two numbers: what your capital base will be worth when you want to borrow, and what the loan will cost. On a guaranteed whole life contract, both are knowable years in advance. On a chassis where crediting caps, spreads, and cost of insurance charges can move within contract limits, both become estimates. You cannot run a disciplined spread calculation against an estimate.

That is why we do not build The And Asset on an indexed universal life policy. The objection is structural, not moral.

04 / How to evaluateHow do you stress test a policy illustration before you buy?

You stress test an illustration by separating what is guaranteed from what is assumed, then pricing the failure case rather than the projection. Most buyers never see this done, because the sales process is built around the current assumption page. The sequence below is what a diligent review looks like, and it applies to whole life and universal life alike.

1. Name the problem before the product. Write down the single job the policy has to do. A capital base you will borrow against, a death benefit that must exist at life expectancy, and a long-term accumulation vehicle are three different assignments with three different right answers.
2. Separate guaranteed from assumed. Ask for the guaranteed column and the current assumption column side by side. On indexed universal life, ask specifically which levers the carrier can adjust and what the contractual maximums are on cost of insurance.
3. Stress test the crediting rate and the timeline. Re-run the projection at a materially lower crediting rate. Extend it to age 95 and age 100, not to life expectancy. Ask for a range of outcomes rather than a single straight line.
4. Price the failure, not the projection. Ask what it costs to keep the policy in force in the first year it strains. If the answer is a six-figure annual premium in your late eighties, that is the number that matters, not the illustrated value at 75.
5. Confirm who maintains it for forty years. A universal life chassis needs annual in-force reviews for decades. Ask what happens if your agent retires, leaves the business, or dies, and whether there is a written succession plan behind the policy.
6. Compare the cost of certainty. Put the guaranteed structure and the assumption-based structure side by side at identical premium. Guarantees buy less death benefit per dollar. Decide whether that difference buys something you need.

Steps four and five are the ones almost nobody runs, and they are where the real risk lives. A policy that projects beautifully at 78 and requires a $600,000 check at 89 is not a projection problem. It is a plan.

Price the bad year. Not the good one.

05 / The mathDoes the deployed return clear the loan cost?

The return on whatever you deploy must exceed the carrier's loan cost, or you should not borrow. That single test governs every And Asset decision, and it is the reason product selection matters more than most agents admit. Policy loan rates vary by carrier and rate environment. At time of writing many carriers fall in the 5 to 6 percent range, and you should treat any specific figure as a variable to verify rather than a constant.

The structure of the decision is simple. You borrow against cash value at the carrier's loan rate. The policy continues compounding on its full value, net of mortality and expense charges and adjusted for the carrier's recognition method. Your deployed capital earns its own return. If that return clears the loan cost, one dollar has done two jobs. If it does not, you have borrowed to lose money slowly.

Run that test against a contract whose internal charges can be repriced and the spread stops being a spread. It becomes a forecast. Uninterrupted compounding is only useful when you can count on the base it compounds against.

If the deal does not clear the loan rate, do not borrow.

06 / The mechanicsWhy do IUL policies underperform their original illustration?

Indexed universal life policies underperform because the index is one input among many, and it is not the input that decides the outcome. Between the index return and your cash value sit the cap, the participation rate, the spread, the premium load, the policy fee, and the cost of insurance charge. The carrier can adjust most of those within contract limits after the policy is issued.

The pattern is visible in the numbers. Products sold roughly a decade ago commonly carried caps in the 10 to 13 percent range. Many of those products were discontinued, and current and in-force caps commonly sit in the 7 to 9 percent range. The illustration was built on the higher number. The performance runs on the lower one.

Actuarial Guideline 49 narrowed the problem without solving it

AG 49, adopted in 2015, capped the maximum rate carriers can use when illustrating indexed crediting and standardized parts of the calculation. Before it, some illustrations showed rates that no realistic cap environment could support. It cleaned up the worst of that. It did not touch what happens after issue, because it governs illustration methodology at the point of sale, not the levers the carrier controls afterward. That is why a decade of post-AG 49 policies is the fair test, and why the challenge uses a ten-year lookback.

Cost of insurance is the part that scales

Cost of insurance is charged against the net amount at risk, which is the gap between the death benefit and the policy value. When crediting underperforms, the policy value falls behind, the net amount at risk widens, and the charge grows. That is a compounding mechanism running in the wrong direction. Late in the contract, at advanced ages, it can turn into six-figure annual charges on a policy that looked healthy at 75. Time makes it worse, not better.

07 / Where it fitsWhere does indexed universal life genuinely make sense?

Indexed universal life makes sense in a narrow set of cases, and estate and wealth transfer planning is the clearest one. When the assignment is maximum death benefit per premium dollar rather than accessible capital, a universal life chassis buys materially more coverage than whole life at the same outlay. In the survivorship case reviewed on the video, roughly $50,000 of annual premium supported about $15 million of death benefit on the indexed design against about $10 million on the whole life design.

That extra $5 million is not free and it is not fraudulent. It is actuarially priced. The buyer is retaining performance and longevity risk that the whole life carrier would otherwise absorb, and receiving more face amount in exchange. Where the design is honest, that trade is disclosed and stress tested up front. Where it is not, the buyer learns about it in their late eighties.

The version of that design we can defend is the one carrying an extended no-lapse guarantee well beyond life expectancy, priced accordingly, reviewed annually, and sold to someone for whom the premium is a small share of total capital. The version we cannot defend is an accumulation design with loans illustrated inside the no-lapse window, which is how the guarantee gets quietly voided.

None of that describes a capital base. A death benefit contract and an And Asset are different instruments solving different problems, and conflating them is how people end up with neither.

08 / The tradeoffsWhat whole life gives up, and what it buys

Whole life buys certainty and pays for it in death benefit per premium dollar, and anyone who tells you otherwise is selling. The guaranteed premium, the guaranteed death benefit, and the guaranteed cash value floor are contractual obligations the carrier prices into the product. That pricing shows up as less face amount at the same outlay.

Three things come with that price. The first is the reduced paid-up option, which has no equivalent on a universal life chassis. On whole life you can stop paying and convert to a smaller, fully paid-up death benefit with certainty. On a universal life policy you either satisfy an extended guarantee, add premium, cut the face amount, or carry the risk. The second is that a design error trends toward correction. A whole life policy built with the wrong emphasis still improves for decades. The third is that the agent's ongoing involvement matters less, because the guarantees do the work the annual review would otherwise have to do.

The honest counterargument is worth stating: if you take the premium difference between a guaranteed universal life design and a whole life design and invest it competently over thirty years, you can build a case that the net outcome is better. That case depends entirely on the discipline of the person making it. Most of the time, the premium difference does not get invested.

Whole life gets missold too. Premium finance designs built on aggressive borrowing assumptions have imploded on both chassis. Policies designed for cash value get sold to people who needed death benefit. Dividend projections get presented as if they were promises. The pattern is roughly one bad whole life design for several bad indexed universal life designs, and neither number is zero. Our own honest assessment of the tradeoffs covers where our own strategy fails.

09 / Head to headIUL vs whole life vs guaranteed UL, on the same premium

At identical premium, the three permanent chassis trade certainty for face amount in a predictable order. The table uses the survivorship figures reviewed in the conversation, where roughly $50,000 of annual premium was modeled across designs on the same two insureds.

10 / The fitWho should walk away from this entire category?

Anyone who cannot name the problem the policy is solving should walk away from all of it, indexed universal life and whole life alike. That sounds obvious. It is the single most common failure we see, and it produces both the lapsed accumulation policy and the overfunded whole life policy sold to someone who needed term coverage and an emergency fund.

If you are early in building wealth, this is not where to start. If you want a savings account alternative, this is not it. If you are carrying significant high-interest debt, a capital strategy that compounds advantages over decades does not solve a liquidity problem this quarter. If you cannot identify a use for borrowed capital that outperforms the loan cost, do not borrow, and probably do not buy.

For the entrepreneur, business owner, real estate investor, or high-income earner who already deploys capital and thinks in opportunity cost, the question narrows to one thing: do you want a contract whose base you can price, or one whose base you have to forecast? Our answer has been consistent across more than 2,000 policies. Yours might reasonably differ, and we would rather you reach it with the failure case in front of you than with the projection alone.

FAQIUL vs whole life questions